[HTML][HTML] Eicosanoid signalling blockade protects middle-aged mice from severe COVID-19
Abstract Coronavirus disease 2019 (COVID-19) is especially severe in aged populations.
Vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are …
Vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are …
Eicosanoid signalling blockade protects middle-aged mice from severe COVID-19
LYR Wong, J Zheng, K Wilhelmsen, K Li… - …, 2022 - pubmed.ncbi.nlm.nih.gov
Coronavirus disease 2019 (COVID-19) is especially severe in aged populations 1. Vaccines
against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are highly effective …
against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are highly effective …
Eicosanoid signalling blockade protects middle-aged mice from severe COVID-19
LYR Wong, J Zheng, K Wilhelmsen, K Li, ME Ortiz… - Nature, 2022 - econpapers.repec.org
Abstract Coronavirus disease 2019 (COVID-19) is especially severe in aged populations1.
Vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are …
Vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are …
Eicosanoid signalling blockade protects middle-aged mice from severe COVID-19
LYR Wong, J Zheng, K Wilhelmsen, K Li, ME Ortiz… - …, 2022 - ui.adsabs.harvard.edu
Abstract Coronavirus disease 2019 (COVID-19) is especially severe in aged populations 1.
Vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are …
Vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are …
Eicosanoid signalling blockade protects middle-aged mice from severe COVID-19.
LR Wong, J Zheng, K Wilhelmsen, K Li, ME Ortiz… - Nature, 2022 - europepmc.org
Abstract Coronavirus disease 2019 (COVID-19) is especially severe in aged populations 1.
Vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are …
Vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are …
[引用][C] Eicosanoid signalling blockade protects middle-aged mice from severe COVID-19
LYR Wong, J Zheng, K Wilhelmsen, K Li, ME Ortiz… - Nature, 2022 - cir.nii.ac.jp
Eicosanoid signalling blockade protects middle-aged mice from severe COVID-19 | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …
Eicosanoid signalling blockade protects middle-aged mice from severe COVID-19
LYR Wong, J Zheng, K Wilhelmsen, K Li, ME Ortiz… - Nature, 2022 - ideas.repec.org
Coronavirus disease 2019 (COVID-19) is especially severe in aged populations1. Vaccines
against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are highly effective …
against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are highly effective …
[HTML][HTML] Eicosanoid signalling blockade protects middle-aged mice from severe COVID-19
LYR Wong, J Zheng, K Wilhelmsen, K Li, ME Ortiz… - Nature, 2022 - ncbi.nlm.nih.gov
Abstract Coronavirus disease 2019 (COVID-19) is especially severe in aged populations 1.
Vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are …
Vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are …
Eicosanoid signalling blockade protects middle-aged mice from severe COVID-19
LYR Wong, J Zheng, K Wilhelmsen, K Li, ME Ortiz… - Nature …, 2022 - iro.uiowa.edu
Abstract Coronavirus disease 2019 (COVID-19) is especially severe in aged populations (1).
Vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are …
Vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are …
Eicosanoid signalling blockade protects middle-aged mice from severe COVID-19
LYR Wong, J Zheng, K Wilhelmsen, K Li, ME Ortiz… - 2022 - digital.csic.es
Coronavirus disease 2019 (COVID-19) is especially severe in aged populations1. Vaccines
against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are highly effective …
against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are highly effective …